Choroideremia — An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
Citation(s)
An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein-1 (REP1)